UPDATE | August 27, 2025

Organoids, ADCs, and more on the horizon at Samsung Biologics

  • MAIL


In a video interview with Pharma’s Almanac, Kevin Sharp, EVP and Head of Sales and Operation, shares insights on Samsung Organoids, which enables clients to better model patient response in the R&D of novel molecules, and highlights our ADC facility, providing full antibody development, manufacturing, and conjugation services. 


Watch the interview to learn more about the latest business updates, including expansion into research services and ADC drug product development on the horizon.


In a video interview with Pharma’s Almanac, Kevin Sharp, EVP and Head of Sales and Operation, shares insights on Samsung Organoids, which enables clients to better model patient response in the R&D of novel molecules, and highlights our ADC facility, providing full antibody development, manufacturing, and conjugation services. 


Watch the interview to learn more about the latest business updates, including expansion into research services and ADC drug product development on the horizon.

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required